Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Anteris Technologies Global Corp.
Anteris Receives First European Regulatory Clearance to Commence DurAVR® THV Global Pivotal Trial (the “PARADIGM Trial”)
October 15, 2025
From
Anteris Technologies Global Corp.
Via
GlobeNewswire
Tickers
ASX:AVR
AVR
Anteris Technologies Global Corp. Announces Adjournment of Special Meeting of Stockholders
September 19, 2025
From
Anteris Technologies Global Corp.
Via
GlobeNewswire
Tickers
ASX:AVR
AVR
Anteris Technologies Global Corp. Announces Postponement of Special Meeting of Stockholders
September 11, 2025
From
Anteris Technologies Global Corp.
Via
GlobeNewswire
Tickers
ASX:AVR
AVR
Anteris Technologies Global Corp. Announces Postponement of Special Meeting of Stockholders
September 04, 2025
From
Anteris Technologies Global Corp.
Via
GlobeNewswire
Tickers
ASX:AVR
AVR
Anteris Announces Results for the Second Quarter of 2025
August 11, 2025
From
Anteris Technologies Global Corp.
Via
GlobeNewswire
Tickers
ASX:AVR
AVR
Anteris Appoints David Roberts and Gregory Moss to its Board of Directors
June 09, 2025
From
Anteris Technologies Global Corp.
Via
GlobeNewswire
Tickers
ASX:AVR
AVR
LMAT
Anteris Announces Results for the First Quarter of 2025
May 13, 2025
From
Anteris Technologies Global Corp.
Via
GlobeNewswire
Tickers
ASX:AVR
AVR
Anteris Technologies Reaches Clinical Milestone: 100 patients treated with DurAVR® THV
March 31, 2025
From
Anteris Technologies Global Corp.
Via
GlobeNewswire
Tickers
ASX:AVR
AVR
Anteris Reports One-Year Patient Outcomes for DurAVR® THV
March 21, 2025
From
Anteris Technologies Global Corp.
Via
GlobeNewswire
Tickers
ASX:AVR
AVR
Anteris Reports 2024 Financial Results and Provides Corporate Update
March 12, 2025
From
Anteris Technologies Global Corp.
Via
GlobeNewswire
Tickers
ASX:AVR
AVR
Anteris to Present at Healthcare Investor Conferences - TD Cowen and Barclays
February 28, 2025
From
Anteris Technologies Global Corp.
Via
GlobeNewswire
Tickers
ASX:AVR
AVR
Anteris Technologies Global Corp. Announces Closing of $88.8 Million U.S. Initial Public Offering
December 16, 2024
From
Anteris Technologies Global Corp.
Via
Business Wire
Tickers
ASX:AVR
AVR
Anteris Technologies Global Corp. Announces Pricing of U.S. Initial Public Offering
December 12, 2024
From
Anteris Technologies Global Corp.
Via
Business Wire
Tickers
ASX:AVR
Anteris Technologies Global Corp. Announces Launch of U.S. Initial Public Offering
December 09, 2024
From
Anteris Technologies Global Corp.
Via
Business Wire
Tickers
ASX:AVR
Anteris Technologies Global Corp. Files Registration Statement for Proposed US Initial Public Offering
November 24, 2024
From
Anteris Technologies Global Corp.
Via
Business Wire
Tickers
ASX:AVR
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today